Talha Badar

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 97

Top Venues

Blood cancer journal

American journal of hematology

Blood

Blood advances

Mayo Clinic

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mayo Clinic Jul 20 2020

United States

Leukemia Attending :: Hematology and Oncology

Publications

Frederick L Locke, Tanya Siddiqi, Caron A Jacobson, Armin Ghobadi, Sairah A Ahmed, David Bernard Miklos, Miguel-Ángel Perales, Javier Munoz, Warren B Fingrut, Martina Pennisi, Jordan Gauthier, Mazyar Shadman, Lohith Gowda, Abu-Sayeef Mirza, Muhammad Bilal Abid, Sanghee Hong, Navneet S Majhail, Mohamed A Kharfan-Dabaja, Arushi Khurana, Talha Badar, Yi Lin, N Nora Bennani, Megan M Herr, Zhen-Huan Hu, Hai-Lin Wang, Anjani Baer, Elande Baro, Harry Miao, Clare Spooner, Hairong Xu, Marcelo C Pasquini
Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity. Blood 143 (26) (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology 99 (4) (2024)
Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology 99 (4) (2024)
Zhuoer Xie, Rami S Komrokji, Najla Al-Ali, Alexandra Regelson, Susan Geyer, Anand Ashwin Patel, Caner Saygin, Amer M Zeidan, Jan Philipp Bewersdorf, Lourdes M Mendez, Ashwin Kishtagari, Joshua F Zeidner, Catherine C Coombs, Yazan F Madanat, Stephen S Chung, Talha Badar, James M Foran, Pinkal Desai, Charlton Tsai, Elizabeth A Griffiths, Monzr M Al Malki, Idoroenyi Amanam, Catherine E Lai, H Joachim Deeg, Lionel Ades, Cecilia Arana-Yi, Afaf E G Osman, Shira Naomi Dinner, Yasmin M Abaza, Justin Taylor, Namrata S Chandhok, Deborah Soong, Andrew M Brunner, Hetty E Carraway, Abhay Singh, Chiara Elena, Jacqueline Ferrari, Anna Galli, Sara Pozzi, Eric Padron, Mirinal S Patnaik, Luca Malcovati, Michael R Savona, Aref A Al-Kali
Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence. Blood (2024)
Frederick L Locke, Tanya Siddiqi, Caron A Jacobson, Armin Ghobadi, Sairah A Ahmed, David Bernard Miklos, Miguel-Ángel Perales, Javier Munoz, Warren B Fingrut, Martina Pennisi, Jordan Gauthier, Mazyar Shadman, Lohith Gowda, Abu-Sayeef Mirza, Muhammad Bilal Abid, Sanghee Hong, Navneet S Majhail, Mohamed A Kharfan-Dabaja, Arushi Khurana, Talha Badar, Yi Lin, N Nora Bennani, Megan M Herr, Zhen-Huan Hu, Hailin Wang, Anjani Baer, Elande Baro, Harry Miao, Clare Spooner, Hairong Xu, Marcelo C Pasquini
Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity. Blood (2024)
Razan Mohty, Tea Reljic, Nayef Abdel-Razeq, Omer Jamy, Talha Badar, Ambuj Kumar, Mahmoud Aljurf, Mohamed A Kharfan-Dabaja
Assessing the efficacy of allogeneic hematopoietic cell transplantation in VEXAS syndrome: results of a systematic review and meta-analysis. Bone marrow transplantation (2024)
Frederick L Locke, Tanya Siddiqi, Caron A Jacobson, Armin Ghobadi, Sairah A Ahmed, David Bernard Miklos, Miguel-Ángel Perales, Javier Munoz, Warren B Fingrut, Martina Pennisi, Jordan Gauthier, Mazyar Shadman, Lohith Gowda, Abu-Sayeef Mirza, Muhammad Bilal Abid, Sanghee Hong, Navneet S Majhail, Mohamed A Kharfan-Dabaja, Arushi Khurana, Talha Badar, Yi Lin, N Nora Bennani, Megan M Herr, Zhen-Huan Hu, Hai-Lin Wang, Anjani Baer, Elande Baro, Harry Miao, Clare Spooner, Hairong Xu, Marcelo C Pasquini
Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity. Blood 143 (26) (2024)
Frederick L Locke, Tanya Siddiqi, Caron A Jacobson, Armin Ghobadi, Sairah A Ahmed, David Bernard Miklos, Miguel-Ángel Perales, Javier Munoz, Warren B Fingrut, Martina Pennisi, Jordan Gauthier, Mazyar Shadman, Lohith Gowda, Abu-Sayeef Mirza, Muhammad Bilal Abid, Sanghee Hong, Navneet S Majhail, Mohamed A Kharfan-Dabaja, Arushi Khurana, Talha Badar, Yi Lin, N Nora Bennani, Megan M Herr, Zhen-Huan Hu, Hai-Lin Wang, Anjani Baer, Elande Baro, Harry Miao, Clare Spooner, Hairong Xu, Marcelo C Pasquini
Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity. Blood 143 (26) (2024)
Tania Jain, Noel Estrada-Merly, María Queralt Salas, Soyoung Kim, Jakob DeVos, Min Chen, Xi Fang, Rajat Kumar, Marcio Andrade-Campos, Hany Elmariah, Vaibhav Agrawal, Mahmoud Aljurf, Vera Ulrike Bacher, Talha Badar, Sherif M Badawy, Karen Ballen, Amer Beitinjaneh, Vijaya Raj Bhatt, Christopher Bredeson, Zachariah DeFilipp, Bhagirathbhai R Dholaria, Nosha Farhadfar, Shatha Farhan, Arpita P Gandhi, Siddhartha Ganguly, Usama Gergis, Michael R Grunwald, Nada Hamad, Betty K Hamilton, Yoshihiro Inamoto, Madiha Iqbal, Omer H Jamy, Mark B Juckett, Mohamed A Kharfan-Dabaja, Maxwell M Krem, Deepesh P Lad, Jane Liesveld, Monzr M Al Malki, Adriana K Malone, Hemant S Murthy, Guillermo Ortí, Sagar S Patel, Attaphol Pawarode, Miguel-Ángel Perales, Marjolein van der Poel, Olle Ringdén, David A Rizzieri, Alicia Rovo, Bipin P Savani, Mary Lynn Savoie, Sachiko Seo, Melhem Solh, Celalettin Ustun, Leo F Verdonck, John R Wingard, Baldeep Wirk, Nelli Bejanyan, Richard J Jones, Taiga Nishihori, Betul Oran, Ryotaro Nakamura, Bart L Scott, Wael Saber, Vikas K Gupta
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study. Blood advances 8 (16) (2024)
Razan Mohty, Tea Reljic, Nayef Abdel-Razeq, Omer Jamy, Talha Badar, Ambuj Kumar, Mahmoud Aljurf, Mohamed A Kharfan-Dabaja
Assessing the efficacy of allogeneic hematopoietic cell transplantation in VEXAS syndrome: results of a systematic review and meta-analysis. Bone marrow transplantation (2024)
Talha Badar, Selina M Luger, Mark R Litzow
Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemia. Blood (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Tania Jain, Noel Estrada-Merly, María Queralt Salas, Soyoung Kim, Jakob D DeVos, Min Chen, Xi Fang, Rajat Kumar, Marcio Andrade-Campos, Hany Elmariah, Vaibhav Agrawal, Mahmoud Aljurf, Vera Ulrike Bacher, Talha Badar, Sherif M Badawy, Karen Kuhn Ballen, Amer Beitinjaneh, Vijaya Raj Bhatt, Christopher N Bredeson, Zachariah DeFilipp, Bhagirathbhai R Dholaria, Nosha Farhadfar, Shatha Farhan, Arpita Gandhi, Siddhartha Ganguly, Usama Gergis, Michael R Grunwald, Nada Hamad, Betty K Hamilton, Yoshihiro Inamoto, Madiha Iqbal, Omer H Jamy, Mark B Juckett, Mohamed A Kharfan-Dabaja, Maxwell M Krem, Deepesh P Lad, Jane L Liesveld, Monzr M Al Malki, Adriana K Malone, Hemant S Murthy, Guillermo Ortí, Sagar S Patel, Attaphol Pawarode, Miguel-Ángel Perales, Marjolein W M van der Poel, Olle Ringdén, David A Rizzieri, Alicia Rovo, Bipin P Savani, Mary Lynn Savoie, Sachiko Seo, Melhem M Solh, Celalettin Ustun, Leo F Verdonck, John R Wingard, Baldeep Wirk, Nelli Bejanyan, Richard J Jones, Taiga Nishihori, Betul Oran, Ryotaro Nakamura, Bart L Scott, Wael Saber, Vikas K Gupta
Donor Types and Outcomes of Transplantation in Myelofibrosis: A CIBMTR Study. Blood advances (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Tania Jain, Noel Estrada-Merly, María Queralt Salas, Soyoung Kim, Jakob DeVos, Min Chen, Xi Fang, Rajat Kumar, Marcio Andrade-Campos, Hany Elmariah, Vaibhav Agrawal, Mahmoud Aljurf, Vera Ulrike Bacher, Talha Badar, Sherif M Badawy, Karen Ballen, Amer Beitinjaneh, Vijaya Raj Bhatt, Christopher Bredeson, Zachariah DeFilipp, Bhagirathbhai R Dholaria, Nosha Farhadfar, Shatha Farhan, Arpita P Gandhi, Siddhartha Ganguly, Usama Gergis, Michael R Grunwald, Nada Hamad, Betty K Hamilton, Yoshihiro Inamoto, Madiha Iqbal, Omer H Jamy, Mark B Juckett, Mohamed A Kharfan-Dabaja, Maxwell M Krem, Deepesh P Lad, Jane Liesveld, Monzr M Al Malki, Adriana K Malone, Hemant S Murthy, Guillermo Ortí, Sagar S Patel, Attaphol Pawarode, Miguel-Ángel Perales, Marjolein van der Poel, Olle Ringdén, David A Rizzieri, Alicia Rovo, Bipin P Savani, Mary Lynn Savoie, Sachiko Seo, Melhem Solh, Celalettin Ustun, Leo F Verdonck, John R Wingard, Baldeep Wirk, Nelli Bejanyan, Richard J Jones, Taiga Nishihori, Betul Oran, Ryotaro Nakamura, Bart L Scott, Wael Saber, Vikas K Gupta
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study. Blood advances 8 (16) (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Narendranath Epperla, Ying Huang, Amanda F Cashen, John L Vaughn, Walter Hanel, Talha Badar, Stefan K Barta, Paolo F Caimi, Tarsheen K Sethi, Nishitha Reddy, Reem Karmali, Celeste Bello, Julio C Chavez, Shalin K Kothari, Francisco J Hernandez-Ilizaliturri, Jakub Svoboda, Frederick Lansigan, Martha J Glenn, Jonathon B Cohen, Caryn Sorge, Beth Christian, Alex F Herrera, Mehdi Hamadani, Luciano José Megale Costa, Ana C Xavier
Evaluation of prognostic factors for high-risk classical Hodgkin lymphoma undergoing autologous transplantation. Blood advances (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Ashwin Patel, Jan Philipp Bewersdorf, Adam S DuVall, Danielle Bradshaw, Yasmin M Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M Zeidan, Vamsi K Kota, Mark R Litzow
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood cancer journal 14 (1) (2024)
Talha Badar, Ravi Narra, Alice S Mims, Michael G Heckman, Rory M Shallis, Sheikh Fahad, Cameron Hunter, Vamsi K Kota, Tamer Adel Othman, Brian A Jonas, Shreya Desai, Guilherme Sacchi de Camargo Correia, Anand Ashwin Patel, Adam S DuVall, Neil Palmisiano, Emily Curran, Zulfa Omer, Anjali S Advani, Ehab Atallah, Mark R Litzow
Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional study. American journal of hematology (2024)
Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology 99 (4) (2024)
Frederick L Locke, Tanya Siddiqi, Caron A Jacobson, Armin Ghobadi, Sairah A Ahmed, David Bernard Miklos, Miguel-Ángel Perales, Javier Munoz, Warren B Fingrut, Martina Pennisi, Jordan Gauthier, Mazyar Shadman, Lohith Gowda, Abu-Sayeef Mirza, Muhammad Bilal Abid, Sanghee Hong, Navneet S Majhail, Mohamed A Kharfan-Dabaja, Arushi Khurana, Talha Badar, Yi Lin, N Nora Bennani, Megan M Herr, Zhen-Huan Hu, Hai-Lin Wang, Anjani Baer, Elande Baro, Harry Miao, Clare Spooner, Hairong Xu, Marcelo C Pasquini
Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity. Blood 143 (26) (2024)
Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology (2024)
Naseema Gangat, Helen Ajufo, Maymona Abdelmagid, Omer Karrar, Kristen McCullough, Talha Badar, James M Foran, Jeanne Palmer, Hassan B Alkhateeb, Abhishek A Mangaonkar, Andrew T Kuykendall, Raajit K Rampal, Ayalew Tefferi
IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience. British journal of haematology (2023)
Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref A Al-Kali, Abhishek A Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Vinod Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mirinal S Patnaik
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 13 (1) (2023)
Omer S Karrar, Maymona Abdelmagid, Masooma Rana, Moazah Iftikhar, McCullough Kristen, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Michelle A Elliott, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi, Mark R Litzow, William Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Talha Badar, Hemant S Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y Arana Yi, Ayalew Tefferi, Naseema Gangat
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival. American journal of hematology 99 (2) (2023)
Mark Gurney, Ismahene Chekkaf, Anmol Baranwal, Rami Basmaci, Bahga Katamesh, Patricia Greipp, James M Foran, Talha Badar, Abhishek A Mangaonkar, Kebede H Begna, Naseema Gangat, Mrinal M Patnaik, Mark R Litzow, Mithun Vinod Shah, David S Viswanatha, Rong He, Hassan B Alkhateeb, Aref A Al-Kali
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms. British journal of haematology (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): a Mayo-Moffitt study of 156 informative cases. American journal of hematology (2023)
Rimal Ilyas, McCullough Kristen, Talha Badar, Mirinal S Patnaik, Hassan B Alkhateeb, Abhishek A Mangaonkar, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases. Blood cancer journal 13 (1) (2023)
Naseema Gangat, Omer S Karrar, Moazah Iftikhar, McCullough Kristen, Isla M Johnson, Maymona Abdelmagid, Mostafa Abdallah, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi, Mark R Litzow, William Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Talha Badar, Hemant S Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y Arana Yi, Ayalew Tefferi
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients. American journal of hematology (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology (2023)
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M Badawy, Minoo Battiwalla, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I Brown, Paul Castillo, Jan Cerny, Edward A Copelan, Charles F Craddock, Bhagirathbhai R Dholaria, Miguel Angel Diaz Perez, Christen L Ebens, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R Grunwald, Shahrukh Hashmi, Gerhard Carl Hildebrandt, Madiha Iqbal, Omer Jamy, Mohamed A Kharfan-Dabaja, Nandita Khera, Hillard M Lazarus, Richard J Lin, Dipenkumar Modi, Sunita Nathan, Taiga Nishihori, Sagar S Patel, Attaphol Pawarode, Wael Saber, Akshay Sharma, Melham M Solh, John L Wagner, Trent P Wang, Kirsten M Williams, Lena E Winestone, Baldeep Wirk, Amer Zeidan, Christopher S Hourigan, Mark R Litzow, Partow Kebriaei, Marcos de Lima, Kristin Page, Daniel J Weisdorf
Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients. Leukemia (2023)
Rimal Ilyas, McCullough Kristen, Talha Badar, Mirinal S Patnaik, Hassan B Alkhateeb, Abhishek A Mangaonkar, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases. Blood cancer journal 13 (1) (2023)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika Kutyna, Hassan Alkhateeb, Talha Badar, Paul Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter Bardy, Ashanka Beligaswatte, David Yeung, Mark R Litzow, Abhishek Mangaonkar, Pratyush Giri, Cindy Lee, Angie Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung H Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood 141 (9) (2023)
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M Badawy, Minoo Battiwalla, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I Brown, Paul Castillo, Jan Cerny, Edward A Copelan, Charles F Craddock, Bhagirathbhai R Dholaria, Miguel Angel Diaz Perez, Christen L Ebens, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R Grunwald, Shahrukh Hashmi, Gerhard Carl Hildebrandt, Madiha Iqbal, Omer Jamy, Mohamed A Kharfan-Dabaja, Nandita Khera, Hillard M Lazarus, Richard J Lin, Dipenkumar Modi, Sunita Nathan, Taiga Nishihori, Sagar S Patel, Attaphol Pawarode, Wael Saber, Akshay Sharma, Melham M Solh, John L Wagner, Trent P Wang, Kirsten M Williams, Lena E Winestone, Baldeep Wirk, Amer Zeidan, Christopher S Hourigan, Mark R Litzow, Partow Kebriaei, Marcos de Lima, Kristin Page, Daniel J Weisdorf
Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients. Leukemia (2023)
Omer S Karrar, Maymona Abdelmagid, Masooma Rana, Moazah Iftikhar, McCullough Kristen, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Michelle A Elliott, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi, Mark R Litzow, William Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Talha Badar, Hemant S Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y Arana Yi, Ayalew Tefferi, Naseema Gangat
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival. American journal of hematology 99 (2) (2023)
Talha Badar, Ehab Atallah, Rory Michael Shallis, Antoine N Saliba, Anand Ashwin Patel, Jan P Bewersdorf, Justin Grenet, Maximilian Stahl, Adam Duvall, Madelyn Burkart, Neil Palmisiano, Danielle Bradshaw, Michal Kubiak, Shira Dinner, Aaron D Goldberg, Yasmin Abaza, Guru Subramanian Guru Murthy, Vamsi K Kota, Mark R Litzow
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Leukemia (2023)
Ayalew Tefferi, Farah Fleti, Onyee Chan, Najla H Al Ali, Aref A Al-Kali, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Mithun Vinod Shah, Devendra K Hiwase, Eric Padron, David A Sallman, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q). British journal of haematology (2023)
Rimal Ilyas, McCullough Kristen, Talha Badar, Mirinal S Patnaik, Hassan B Alkhateeb, Abhishek A Mangaonkar, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases. Blood cancer journal 13 (1) (2023)
Rimal Ilyas, McCullough Kristen, Talha Badar, Mirinal S Patnaik, Hassan B Alkhateeb, Abhishek A Mangaonkar, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases. Blood cancer journal 13 (1) (2023)
Mostafa Abdallah, McCullough Kristen, Rimal Ilyas, Kebede H Begna, Aref A Al-Kali, Mark R Litzow, William Joseph Hogan, Abhishek A Mangaonkar, Hassan B Alkhateeb, Mithun Vinod Shah, Michelle A Elliott, James M Foran, Talha Badar, Jeanne M Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mirinal S Patnaik, Horatiu Olteanu, Rhett P Ketterling, Ayalew Tefferi, Naseema Gangat
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Blood cancer journal 13 (1) (2023)
Rimal Ilyas, McCullough Kristen, Talha Badar, Mirinal S Patnaik, Hassan B Alkhateeb, Abhishek A Mangaonkar, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases. Blood cancer journal 13 (1) (2023)
Mostafa Abdallah, McCullough Kristen, Rimal Ilyas, Kebede H Begna, Aref A Al-Kali, Mark R Litzow, William Joseph Hogan, Abhishek A Mangaonkar, Hassan B Alkhateeb, Mithun Vinod Shah, Michelle A Elliott, James M Foran, Talha Badar, Jeanne M Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mirinal S Patnaik, Horatiu Olteanu, Rhett P Ketterling, Ayalew Tefferi, Naseema Gangat
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Blood cancer journal 13 (1) (2023)
Alejandro Ferrer, Terra L Lasho, Jenna A Fernandez, Nickolas P Steinauer, Rachel A Simon, Christy M Finke, Eva M Carmona, Mark E Wylam, Laura J Ongie, Brittany N Burnap, Cecilia Y Arana Yi, Lisa Z Sproat, James Foran, Talha Badar, Abhishek A Mangaonkar, Mirinal S Patnaik
Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variants. American journal of hematology (2023)
Ahmad Nanaa, Rong He, James M Foran, Talha Badar, Naseema Gangat, Animesh D Pardanani, William J Hogan, Mark R Litzow, Mrinal Patnaik, Aref A Al-Kali, Hassan B Alkhateeb
Venetoclax plus hypomethylating agents in DDX41-mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patients. British journal of haematology (2023)
Mostafa Abdallah, McCullough Kristen, Rimal Ilyas, Kebede H Begna, Aref A Al-Kali, Mark R Litzow, William Joseph Hogan, Abhishek A Mangaonkar, Hassan B Alkhateeb, Mithun Vinod Shah, Michelle A Elliott, James M Foran, Talha Badar, Jeanne M Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mirinal S Patnaik, Horatiu Olteanu, Rhett P Ketterling, Ayalew Tefferi, Naseema Gangat
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Blood cancer journal 13 (1) (2023)
Mostafa Abdallah, McCullough Kristen, Rimal Ilyas, Kebede H Begna, Aref A Al-Kali, Mark R Litzow, William Joseph Hogan, Abhishek A Mangaonkar, Hassan B Alkhateeb, Mithun Vinod Shah, Michelle A Elliott, James M Foran, Talha Badar, Jeanne M Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mirinal S Patnaik, Horatiu Olteanu, Rhett P Ketterling, Ayalew Tefferi, Naseema Gangat
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Blood cancer journal 13 (1) (2023)
Hemant S Murthy, Mei-Jie Zhang, Karen Chen, Sairah A Ahmed, Uday Deotare, Siddhartha Ganguly, Ankit Kansagra, Fotios V Michelis, Taiga Nishihori, Mirinal S Patnaik, Muhammad Bilal Abid, Mahmoud Aljurf, Yasuyuki Arai, Ulrike Bacher, Talha Badar, Sherif M Badawy, Karen Ballen, Minoo Battiwalla, Amer Beitinjaneh, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie Inez Brown, Rodrigo Martino, Jean-Yves Cahn, Paul Castillo, Jan Cerny, Saurabh Chhabra, Edward A Copelan, Andrew Daly, Bhagirathbhai R Dholaria, Miguel Angel Diaz Perez, César O Freytes, Michael R Grunwald, Shahrukh K. Hashmi, Gerhard C Hildebrandt, Omer H Jamy, Jacinth Joseph, Christopher G Kanakry, Nandita Khera, Maxwell M Krem, Yachiyo Kuwatsuka, Hillard M Lazarus, Lazaros J Lekakis, Hongtao Liu, Dipenkumar Modi, Pashna Munshi, Alberto Mussetti, Neil Palmisiano, Sagar S Patel, David A Rizzieri, Sachiko Seo, Mithun Vinod Shah, Akshay Sharma, Melhem M Solh, Scott R Solomon, Matthew L Ulrickson, Celalettin Ustun, Marjolein W M van der Poel, Leo F Verdonck, John L Wagner, Trent P Wang, Baldeep Wirk, Amer M Zeidan, Mark R Litzow, Partow Kebriaei, Christopher S Hourigan, Daniel J Weisdorf, Wael Saber, Mohamed A Kharfan-Dabaja
Allogeneic Hematopoietic Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: a CIBMTR analysis. Blood advances (2023)
Talha Badar, Yazan F Madanat, Amer M Zeidan
Updates on risk stratification and management of lower-risk myelodysplastic syndromes/neoplasms. Future oncology (London, England) (2023)
Omer S Karrar, Maymona Abdelmagid, Masooma Rana, Moazah Iftikhar, McCullough Kristen, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Michelle A Elliott, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi, Mark R Litzow, William Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Talha Badar, Hemant S Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y Arana Yi, Ayalew Tefferi, Naseema Gangat
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival. American journal of hematology (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Maymona G Abdelmagid, Aref A Al-Kali, Mark R Litzow, Kebede H Begna, William Joseph Hogan, Mirinal S Patnaik, Shahrukh K. Hashmi, Michelle A Elliott, Hassan B Alkhateeb, Omer S Karrar, Farah Fleti, Mohammed H Elnayir, Candido E Rivera, Hemant S Murthy, James M Foran, Mohamed A Kharfan-Dabaja, Talha Badar, David S Viswanatha, Kaaren K Reichard, Naseema Gangat, Ayalew Tefferi
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events. Blood cancer journal 13 (1) (2023)
Rimal Ilyas, McCullough Kristen, Talha Badar, Mirinal S Patnaik, Hassan B Alkhateeb, Abhishek A Mangaonkar, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases. Blood cancer journal 13 (1) (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Rimal Ilyas, McCullough Kristen, Talha Badar, Mirinal S Patnaik, Hassan B Alkhateeb, Abhishek A Mangaonkar, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases. Blood cancer journal 13 (1) (2023)
Omer S Karrar, Maymona Abdelmagid, Masooma Rana, Moazah Iftikhar, McCullough Kristen, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Michelle A Elliott, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi, Mark R Litzow, William Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Talha Badar, Hemant S Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y Arana Yi, Ayalew Tefferi, Naseema Gangat
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival. American journal of hematology 99 (2) (2023)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika Kutyna, Hassan Alkhateeb, Talha Badar, Paul Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter Bardy, Ashanka Beligaswatte, David Yeung, Mark R Litzow, Abhishek Mangaonkar, Pratyush Giri, Cindy Lee, Angie Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung H Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood 141 (9) (2023)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika Kutyna, Hassan Alkhateeb, Talha Badar, Paul Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter Bardy, Ashanka Beligaswatte, David Yeung, Mark R Litzow, Abhishek Mangaonkar, Pratyush Giri, Cindy Lee, Angie Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung H Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood 141 (9) (2023)
Aref A Al-Kali, Ahmad Nanaa, David Viswanatha, Rong He, Phuong Nguyen, Dragan Jevremovic, James M Foran, Cecelia Arana Yi, Patricia T Greipp, Naseema Gangat, Mirinal S Patnaik, Ayalew Tefferi, Mark R Litzow, Abhishek A Mangaonkar, Mithun Vinod Shah, Talha Badar, Hassan B Alkhateeb
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome. Blood cancer journal 13 (1) (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Talha Badar, Timothy Chlon
Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms. Current hematologic malignancy reports 17 (5) (2022)
Ahmad Ghorab, Aref A Al-Kali, Michelle Elliot, Naseema Gangat, Hassan B Alkhateeb, Mithun Vinod Shah, Yuanhang Liu, Cecilia Arana Yi, Hemant Murthy, Mohamed A Kharfan-Dabaja, Ayalew Tefferi, Mirinal S Patnaik, Mark Litzow, Talha Badar
Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs. Blood cancer journal 12 (6) (2022)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty M Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika M Kutyna, Hassan B Alkhateeb, Talha Badar, Paul Po-Shen Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter G Bardy, Ashanka Beligaswatte, David T Yeung, Mark R Litzow, Abhishek A Mangaonkar, Pratyush Giri, Cindy H Lee, Angelina Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William J Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung Hoow Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood (2022)
David A Bond, Jeffrey M Switchenko, Diego R Villa, Kami Maddocks, Michael Churnetski, Alina S Gerrie, Subir Goyal, Krithika Shanmugasundaram, Oscar Calzada, Bhaskar C Kolla, Veronika Bachanova, James N Gerson, Stefan K Barta, Brian T Hill, Yazeed Sawalha, Peter Martin, Edward B Maldonado, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Nilanjan Ghosh, Steven I Park, Narendranath Epperla, Talha Badar, Jin Guo, Mehdi Hamadani, Timothy S Fenske, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Kristie A Blum, Jonathon B Cohen
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy. Blood advances 5 (23) (2022)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty M Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika M Kutyna, Hassan B Alkhateeb, Talha Badar, Paul Po-Shen Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter G Bardy, Ashanka Beligaswatte, David T Yeung, Mark R Litzow, Abhishek A Mangaonkar, Pratyush Giri, Cindy H Lee, Angelina Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William J Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung Hoow Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood (2022)
Yenny Moreno Vanegas, Talha Badar
Clinical Utility of Azacitidine in the Management of Acute Myeloid Leukemia: Update on Patient Selection and Reported Outcomes. Cancer management and research 14 (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Naseema Gangat, McCullough Kristen, Isla Johnson, Aref Al-Kali, Kebede H Begna, Mirinal S Patnaik, Mark R Litzow, William Hogan, Mithun Vinod Shah, Hassan Alkhateeb, Abhishek A Mangaonkar, James M Foran, Talha Badar, Jeanne M Palmer, Lisa Sproat, Cecilia Y Arana Yi, Animesh D Pardanani, Ayalew Tefferi
Real-world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts. American journal of hematology 97 (6) (2022)
Anmol Baranwal, Ahmad Nanaa, David Viswanatha, Rong He, James M Foran, Talha Badar, William Joseph Hogan, Mark R Litzow, Mithun Vinod Shah, Mirinal S Patnaik, Aref Al-Kali, Hassan B Alkhateeb
Outcomes of allogeneic transplant in patients with DDX41 mutated myelodysplastic syndrome and acute myeloid leukemia. Bone marrow transplantation 57 (11) (2022)
Talha Badar, Ehab Atallah, Rory M Shallis, Aaron D Goldberg, Anand Ashwin Patel, Yasmin Abaza, Jan Philipp Bewersdorf, Antoine N Saliba, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Adam Duvall, Madelyn Burkart, Maximilian Stahl, Yuanhang Liu, Shira Dinner, Neil Palmisiano, Mark R Litzow, James M Foran
Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival. American journal of hematology 97 (7) (2022)
Bahga Katamesh, Ahmad Nanaa, Rong He, David S Viswanatha, Phuong Nguyen, Patricia T Greipp, Kurt Bessonen, Naseema Gangat, Kebede H Begna, Abhishek A Mangaonkar, Mirinal S Patnaik, William J Hogan, Ayalew Tefferi, Mark R Litzow, Mithun Vinod Shah, Cecilia Arana-Yi, James M Foran, Talha Badar, Hassan B Alkhateeb, Aref A Al-Kali
Clinical and Prognostic Impact of STAG2 Mutations in Myeloid Neoplasms: The Mayo Clinic Experience. Blood advances (2022)
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M Badawy, Minoo Battiwalla, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I Brown, Paul Castillo, Jan Cerny, Edward A Copelan, Charles F Craddock, Bhagirathbhai R Dholaria, Miguel Angel Diaz Perez, Christen L Ebens, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R Grunwald, Shahrukh Hashmi, Gerhard Carl Hildebrandt, Madiha Iqbal, Omer Jamy, Mohamed A Kharfan-Dabaja, Nandita Khera, Hillard M Lazarus, Richard J Lin, Dipenkumar Modi, Sunita Nathan, Taiga Nishihori, Sagar S Patel, Attaphol Pawarode, Akshay Sharma, Melham M Solh, John L Wagner, Trent P Wang, Kirsten M Williams, Lena E Winestone, Baldeep Wirk, Christopher S Hourigan, Mark R Litzow, Partow Kebriaei, Marcos de Lima, Kristin Page, Daniel J Weisdorf
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients. Leukemia (2022)
Naseema Gangat, Deandra Chetram, McCullough Kristen, Aref A Al-Kali, Kebede H Begna, William Hogan, Mark R Litzow, James Foran, Talha Badar, Jeanne Palmer, Mirinal S Patnaik, Animesh D Pardanani, Ayalew Tefferi
Limited activity of luspatercept in myelofibrosis and myeloid neoplasms other than myelodysplastic syndromes with ring sideroblasts. American journal of hematology 97 (12) (2022)
Yenny Moreno Vanegas, Talha Badar
Clinical Utility of Azacitidine in the Management of Acute Myeloid Leukemia: Update on Patient Selection and Reported Outcomes. Cancer management and research 14 (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer (2022)
Amritpal Singh, Aref A Al-Kali, James M Foran, Michelle A Elliott, Kebede H Begna, Talha Badar, Nandita Khera, Farah Fleti, Maymona Abdelmagid, Kareen K Reichard, Rhett P Ketterling, Animesh D Pardanani, Naseema Gangat, Ayalew Tefferi
Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real-world setting. American journal of hematology 97 (10) (2022)
Talha Badar, Alak Manna, Martha E Gadd, Mohamed A Kharfan-Dabaja, Hong Qin
Prospect of CAR T-cell therapy in acute myeloid leukemia. Expert opinion on investigational drugs 31 (2) (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Talha Badar, Mark R Litzow, Rory Michael Shallis, Anand Ashwin Patel, Antoine N Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, Guilherme Sacchi De Camargo Correia, Guru Subramanian Guru Murthy, Yasmin M Abaza, Adam Duvall, Danielle Bradshaw, Vamsi K Kota, Shira Dinner, Aaron D Goldberg, Neil Palmisiano, Aref Al Kali, Ehab Atallah
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. Cancer 129 (6) (2022)
Faiqa Farrukh, Deandra Chetram, Aref Al-Kali, James Foran, Mirinal S Patnaik, Talha Badar, Kebede H Begna, Christopher Hook, William Hogan, McCullough Kristen, Abhishek A Mangaonkar, Rong He, Naseema Gangat, Ayalew Tefferi
Real-world experience with luspatercept and predictors of response in myelodysplastic syndromes with ring sideroblasts. American journal of hematology 97 (6) (2022)
Talha Badar, Aniko Szabo, Mark R Litzow, Madelyn Burkart, Ilana Yurkiewicz, Shira Dinner, Mehrdad Hefazi, Rory M Shallis, Nikolai A Podoltsev, Anand A Patel, Emily Curran, Martha Wadleigh, Suresh Balasubramanian, Jay Yang, Shukaib Arslan, Ibrahim Aldoss, Ryan Mattison, Danielle Cenin, Caitlin Siebenaller, Anjali Advani, Michaela Liedtke, Ehab Atallah
Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data. Bone marrow transplantation 56 (8) (2021)
Hassan B Alkhateeb, Ahmad Nanaa, David S Viswanatha, James M Foran, Talha Badar, Lisa Sproat, Rong He, Phuong Nguyen, Dragan Jevremovic, Mohamad E Salama, Patricia Theresa Greipp, Naseema Gangat, Ayalew Tefferi, Mark R Litzow, Abhishek A Mangaonkar, Mithun Vinod Shah, Mirinal S Patnaik, Aref Al-Kali
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms. Blood advances (2021)
Talha Badar, Ehab Atallah
Do histone deacytelase inhibitors and azacitidine combination hold potential as an effective treatment for high/very-high risk myelodysplastic syndromes? Expert opinion on investigational drugs 30 (6) (2021)
Talha Badar, Parameswaran Hari, Omar Dávila, Raphael Fraser, Baldeep Wirk, Binod Dhakal, Cesar O Freytes, Cesar Rodriguez Valdes, Cindy Lee, David H Vesole, Ehsan Malek, Gerhard C Hildebrandt, Heather Landau, Hemant S Murthy, Hillard M Lazarus, Jesus G Berdeja, Kenneth R Meehan, Melhem Solh, Miguel Angel Diaz, Mohamed A Kharfan-Dabaja, Natalie S Callander, Nosha Farhadfar, Qaiser Bashir, Rammurti T Kamble, Ravi Vij, Reinhold Munker, Robert A Kyle, Saurabh Chhabra, Shahrukh K. Hashmi, Siddhartha Ganguly, Sundar Jagannath, Taiga Nishihori, Yago L Nieto, Shaji K Kumar, Nina Shah, Anita D Souza
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States. Cancer 127 (1) (2020)
Talha Badar, John Astle, Imran K Kakar, Katie Zellner, Parameswaran N Hari, Mehdi Hamadani
Clinical activity of ibrutinib in classical Hodgkin lymphoma relapsing after allogeneic stem cell transplantation is independent of tumor BTK expression. British journal of haematology 190 (2) (2020)
Talha Badar, Bryon D Johnson, Mehdi Hamadani
Delayed neurotoxicity after axicabtagene ciloleucel therapy in relapsed refractory diffuse large B-cell lymphoma. Bone marrow transplantation 56 (3) (2020)
Narendranath Epperla, Talha Badar, Aniko Szabo, John Vaughn, Steve Borson, Neeraj Y Saini, Romil D Patel, Nirav N Shah, Mehdi Hamadani, Sairah Ahmed, Amanda F Cashen, Timothy S Fenske
Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantation. Blood advances 3 (11) (2020)
Talha Badar, Aniko Szabo, Shira Dinner, Michaela Liedtke, Madelyn Burkart, Rory M Shallis, Ilana R Yurkiewicz, Eric Kuo, Muhammad Ali Khan, Suresh Balasubramanian, Jay Yang, Mehrdad Hefazi, Nikolai A Podoltsev, Anand Ashwin Patel, Emily Curran, Amy Wang, Shukaib Arslan, Ibrahim Aldoss, Caitlin Siebenaller, Ryan J Mattison, Mark R Litzow, Martha Wadleigh, Anjali S Advani, Ehab Atallah
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia. Cancer 127 (7) (2020)
Talha Badar, Aniko Szabo, David Sallman, Rami Komrojki, Jefferey Lancet, Eric Padron, Jinming Song, Mohammad Omar Hussaini
Interrogation of molecular profiles can help in differentiating between MDS and AML with MDS-related changes. Leukemia & lymphoma 61 (6) (2020)
Talha Badar, Muhammad Ali Khan, Aniko Szabo, William Drobyski, Saurabh Chhabra, Binod Dhakal, Timothy S Fenske, Mehdi Hamadani, Parameswaran Hari, James H Jerkins, Nirav N Shah, Bronwen E Shaw, Anita D Souza
Incidence and characteristics of engraftment syndrome after autologous hematopoietic cell transplantation in light chain amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 26 (4) (2019)
Talha Badar, Binod Dhakal, Aniko Szabo, Anand Padmanabhan, Bryon D Johnson, Sarah Heidtke, Jean Esselmann, Saurabh Chhabra, Mehdi Hamadani, Parameswaran Hari, Anita D Souza
An updated single center experience with plerixafor and granulocyte colony-stimulating factor for stem cell mobilization in light chain amyloidosis. Journal of clinical apheresis 34 (6) (2019)
Talha Badar, Anita D'Souza, Parameswaran Hari
Recent advances in understanding and treating immunoglobulin light chain amyloidosis. F1000Research 7 (2018)
Talha Badar, Mehdi Hamadani, Veronika Bachanova, Kami J Maddocks, Elvira Umyarova, Julio C Chavez, Narendranath Epperla, Saurabh Chhabra, Ana C Xavier, Reem Karmali, Mohammed Salhab, Nishitha Reddy, Martha J Glenn, Francisco J Hernandez-Ilizaliturri, Christopher R Flowers, Andrew M Evens, Zheng Zhou, Frederick Lansigan, Stefan K Barta, Jonathon B Cohen, Timothy S Fenske, Luciano J Costa
Efficacy of salvage chemotherapy in diffuse large B cell lymphoma with primary treatment failure according to putative cell of origin. Leukemia & lymphoma 60 (4) (2018)

Talha Badar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Talha Badar